Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business Sort descending
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Sort descending Area funzionale Data di pubblicazione
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Giappone Finance CTS Audit e finanza Giu 26, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Giappone Operations CTS Tecnologia dell'informazione Lug 22, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Giappone Finance CTS Audit e finanza Ott 06, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Mag 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Mag 20, 2024
Revenue Accounting Manager Shanghai (Shanghai) Cina Finance CTS Audit e finanza Lug 17, 2024
In-Market Brands Lead Jordan Giordania International Innovative Medicines BD&L & Strategic Planning Ott 16, 2024
SSO Study Start-Up Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Ott 16, 2024
Maintenance Specialist Ivrea Italia International Innovative Medicines Technical Operations Ott 16, 2024
Head of R&D Legal, R&D Transactions and Technical Research & Development Basel (City) Svizzera Legal Innovative Medicines Proprietà legali e intellettuali e conformità Ott 16, 2024
Director, Development Unit Management Basel (City) Svizzera Development Innovative Medicines Research & Development Ott 16, 2024
Senior Pharmareferent (m/w/d), Onkologie / Urologie / RLT, Gebiet: Rheinland-Pfalz & Saarland Saarland (Novartis Pharma GmbH) Germania International Innovative Medicines I saldi Ott 16, 2024
Commissioning & Qualification Engineer Warehouse & Logistics (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Ott 16, 2024
Manager, Value Stream Morris Plains USA Operations Innovative Medicines Technical Operations Ott 16, 2024
GCP Inspection Project Manager London (The Westworks) Regno Unito Development Innovative Medicines Quality Ott 16, 2024
Marketing Specialist Montreal Canada International Innovative Medicines Marketing Ott 16, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Ott 16, 2024
Senior Expert Science & Technology, Analytical Development East Hanover USA Development Innovative Medicines Research & Development Ott 16, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Ott 16, 2024
Associate Director, Marketing Strategist - Immunology East Hanover USA US Innovative Medicines Marketing Ott 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) Cina International Innovative Medicines I saldi Ott 16, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Ott 17, 2024
Field Product Specialist - Hue Vietnam Vietnam International Innovative Medicines I saldi Ott 16, 2024
RA Operational Excellence Junior Associate – MEA Dubai Emirati Arabi Uniti Development Innovative Medicines Research & Development Ott 16, 2024
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Quality Ott 17, 2024
Lead, QSRC (Quality System Regulatory Compliance) Tuas South Avenue Singapore Operations Innovative Medicines Quality Ott 17, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Ott 17, 2024
Ekspert upravljanja kakovosti za proces proizvodnje bioloških učinkovin (m/ž/d) / QA expert for the production process of biological agents (m/f/d) Mengeš Slovenia Operations Innovative Medicines Quality Ott 17, 2024
Technical Services Leader Targu Mures Romania Operations Innovative Medicines Technical Operations Ott 17, 2024
EXT Equipment Specialist-3 Torre Annunziata Italia Operations Innovative Medicines Technical Operations Ott 17, 2024
Skladiščnik (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Ott 17, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) Francia Development Innovative Medicines Research & Development Ott 17, 2024
Sales Representative (d/w/m), Rheumatologie,Gebiet: Südhessen Hessen (Novartis Pharma GmbH) Germania International Innovative Medicines I saldi Ott 17, 2024
Senior Expert Technical Development- Drug Product Project Lead East Hanover USA Development Innovative Medicines Research & Development Ott 17, 2024
Quality Assurance Manager - QP/RP Amsterdam Paesi Bassi Operations Innovative Medicines Quality Set 17, 2024
Global Labelling Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 17, 2024
SSO Site Partnership Manager Guangzhou (Guangdong Province) Cina Development Innovative Medicines Research & Development Set 17, 2024
Cardiovascular Territory Account Specialist – Falls Church – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 17, 2024
Cardiovascular Institutional Sales Specialist– Boston – Remote Field Sales (USA) USA US Innovative Medicines I saldi Set 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Giappone Finance Innovative Medicines Audit e finanza Set 17, 2024
Expert Science & Technology II- Analytical Research & Development Changshu (Jiangsu Province) Cina Development Innovative Medicines Research & Development Set 18, 2024
Global Program Clinical Head: In-market Brands London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 18, 2024
Senior Expert, Science & Technology - Potency East Hanover USA Development Innovative Medicines Research & Development Set 18, 2024
Executive Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Set 18, 2024
Executive Product Specialist Quanzhou (Fujian Province) Cina International Innovative Medicines I saldi Set 18, 2024
Senior Expert Data Science Hyderabad (Office) India Operations Innovative Medicines Data and Digital Set 18, 2024
Field Force Execution Lead (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Germania International Innovative Medicines Marketing Set 19, 2024
Senior Principal Product Operations Manager Hyderabad (Office) India Biomedical Research Innovative Medicines Research & Development Set 19, 2024
Senior Principal Statistical Programmer - Advanced Quantitative Sciences East Hanover USA Development Innovative Medicines Research & Development Set 19, 2024
Associate Director, Statistical Programming East Hanover USA Development Innovative Medicines Research & Development Set 19, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia